(Bloomberg) More than $6.4 billion in health-care deals were announced on Monday as the annual JPMorgan Healthcare Conference kicked off in San Francisco. Most Read from BloombergMusk’s Drug Use Concerns Tesla, SpaceX Leaders, WSJ SaysBoeing Slumps After Panel Blowout Leads to Partial 737 GroundingChina Says It Caught Foreign Consultant Spying for UK’s MI6The deals include Merck & Co.’s $680 million purchase of cancer drugmaker Harpoon Therapeutics Inc., Boston Scientific Corp.’s $3.7 billion
Intellia Therapeutics acquires a little-known University of California, Berkeley startup for up to $200 million that says it can work on gene editing in non-dividing cell types.
Moderna is doling out a little bit of its COVID-19 vaccine cash in a $45 million oncology research deal with Carisma Therapeutics to develop up to a dozen targets.